M. Hassel

Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial

M. Piérart, MJ van den Bent, D. Áfra, 2005, The Lancet.

Sequential chemotherapy and radiotherapy for patients with squamous cell carcinoma of the esophagus

M. Hassel, J. Raoul, B. Meunier, 1995, Cancer.

Temozolomide chemotherapy versus radiotherapy in molecularly characterized (1p loss) low-grade glioma: A randomized phase III intergroup study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033).

M. Hassel, K. Hoang-Xuan, R. Stupp, 2013 .

A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus

M. Hassel, G. Maddern, B. Meunier, 1994, Cancer.

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma

Brigitta G. Baumert, Jaap C. Reijneveld, Andreas von Deimling, 2016, The Lancet. Oncology.

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

M. Hassel, K. Hoang-Xuan, R. Stupp, 2016, The Lancet. Oncology.

Intra-Arterial Chemotherapy Using Extra-Intracranial by-Pass for the Treatment of Malignant Gliomas

M. Hassel, J. Pecker, P. Bourguet, 1987 .

Syndrome de Stewart-Treves sur lymphœdème chronique post-traumatique

M. Hassel, P. Kerbrat, C. Lefeuvre, 1999 .